National Heart, Lung, and Blood Institute (NHLBI): Hematologic Diseases trials

The registry lists 39 Hematologic Diseases studies with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor. 2 are open to participants now and 1 have results posted.

Phase 1 1Phase 2 6Phase 3 7No phase 25(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Data Collection of Standard Care and Evaluation of NHLBI Patients and DonorsEnrolling by invitationNCT04450927
• Screening for Hematology Branch ProtocolsEnrolling by invitationNCT00001620
• Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell AnemiaCompletedNCT00006400Phase 3Results posted
• Ultra Low Dose Interleukin-2 in Healthy VolunteersCompletedNCT01445561Phase 1
• Screening for Subjects to Participate in Studies of Blood DisordersCompletedNCT00695123
• Natural History Study for BENCompletedNCT00059423
• Transcranial Doppler (TCD) Ultrasound of Subjects Enrolled in BABY HUG - Ancillary to BABY HUGCompletedNCT00059293
• Pediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP IICompletedNCT00037388
• Induction of Stable Chimerism for Sickle Cell AnemiaCompletedNCT00029393Phase 2
• Cord Blood Transplantation for Sickle Cell Anemia and ThalassemiaCompletedNCT00029380Phase 2
• Blood and Marrow Transplant Clinical Research NetworkCompletedNCT00023530Not applicable
• Cytomegalovirus Spread and Reactivation in Blood CellsCompletedNCT00006314
• Stroke Prevention in Sickle Cell Anemia (STOP 2)CompletedNCT00006182Phase 3
• Hemostasis in Sickle Cell Disease--Infancy to AdulthoodCompletedNCT00005703
• Aplastic Anemia Epidemiology: Incidence and Case-controlCompletedNCT00005682
• Statistical Basis for Hemochromatosis ScreeningCompletedNCT00005559
• Retention of Bone Marrow Donors in a National RegistryCompletedNCT00005556
• Hemochromatosis and Iron Overload Screening Study (HEIRS)CompletedNCT00005541
• Epidemiology and Immunology of Hemophilia A InhibitorsCompletedNCT00005518
• Indices of Severity and Prognosis for Sickle Cell DiseaseCompletedNCT00005467
• Neuropsychological Studies of Children With Sickle CellCompletedNCT00005438
• Cerebrovascular Involvement in Sickle Cell Disease - Comprehensive Sickle Cell CenterCompletedNCT00005326
• Anemia and Surgery: Indications For TransfusionCompletedNCT00005308
• Etiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic Anemia Study DataCompletedNCT00005307
• Drug Etiology of Aplastic Anemia and Related DyscrasiasCompletedNCT00005302
• Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell DiseaseCompletedNCT00005300
• Cooperative Study of The Clinical Course of Sickle Cell DiseaseCompletedNCT00005277
• National Health and Nutrition Examination Survey IV (NHANES (IV)CompletedNCT00005154
• Vietnam Era Twin (VET) RegistryCompletedNCT00005126
• Medical Treatment for Diamond Blackfan AnemiaCompletedNCT00001749Phase 2
• Evaluation, Treatment, and Training for Patients With Blood DisordersCompletedNCT00001397
• Cord Blood Stem Cell Transplantation Study (COBLT)CompletedNCT00000603Phase 2
• Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG)CompletedNCT00000602Phase 2
• Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic DisordersCompletedNCT00000597Phase 3
• Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional HemochromatosisCompletedNCT00000595Phase 2
• Trial to Reduce Alloimmunization to Platelets (TRAP)CompletedNCT00000589Phase 3
• Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)CompletedNCT00000586Phase 3
• Penicillin Prophylaxis in Sickle Cell Disease (PROPS)CompletedNCT00000585Phase 3
• Cooperative Study of Factor VIII InhibitorsCompletedNCT00000582Phase 3